INTS vs LVS · $7.7M cap vs P/E 28, rev $2.90B
Intensity Therapeutics, Inc. Common stock (INTS) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported LVS revenue for 2024-12-31 was $2.90B. Net income was $392.0M. Revenue was up 8.0% from 2024-09-30 to 2024-12-31. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
INTS currently screens at market cap $7.7M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the INTS and LVS stock pages for the full models.
Not investment advice.